Introduction/objective: Diagnostic delays in pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) are related to increased morbidity and mortality. The risk of a delayed, or even a missed, diagnosis is high as the conditions are rare. The aim was to describe patients’ and spouses’ experiences of the journey from the first symptom to an established diagnosis. Methods: A secondary analysis of 31 transcripts, based on 2 primary datasets containing interviews with 17 patients and 14 spouses, was carried out and analyzed according to qualitative content analysis. Results: One overarching category was revealed from the content analysis; “The journey from doubt and hope to receive the diagnosis.” Five sub...
Pulmonary arterial hypertension (PAH) is a rare, debilitating and rapidly progressive disease. Altho...
Objective: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (...
Purpose: To describe symptoms experienced by pulmonary arterial hyper-tension (PAH) patients and the...
Introduction/objective: Diagnostic delays in pulmonary arterial hypertension (PAH) and chronic throm...
Objectives To investigate the patient's experience of the trajectory to receiving a diagnosis of pul...
Introduction: Pulmonary fibrosis includes a spectrum of diseases and is incurable. There is a variat...
Background. Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension ...
Copyright © 2014 Bodil Ivarsson et al. This is an open access article distributed under the Creative...
Introduction: Pulmonary fibrosis includes a spectrum of diseases and is incurable. There is a variat...
Survival rates for patients with idiopathic pulmonary arterial hypertension (IPAH) have improved wit...
Introduction: Spouses play a crucial role, both physically and psychologically, for patients with pu...
Introduction: Pulmonary fibrosis includes a spectrum of diseases and is incurable. There is a variat...
Essentials Diagnostic delay of chronic thromboembolic pulmonary hypertension (CTEPH) is long. We exp...
Pulmonary hypertension (PH) is a complex condition that can occur as a result of a wide range of dis...
ABSTRACT: Poor survival among patients with untreated pulmonary arterial hypertension (PAH) means th...
Pulmonary arterial hypertension (PAH) is a rare, debilitating and rapidly progressive disease. Altho...
Objective: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (...
Purpose: To describe symptoms experienced by pulmonary arterial hyper-tension (PAH) patients and the...
Introduction/objective: Diagnostic delays in pulmonary arterial hypertension (PAH) and chronic throm...
Objectives To investigate the patient's experience of the trajectory to receiving a diagnosis of pul...
Introduction: Pulmonary fibrosis includes a spectrum of diseases and is incurable. There is a variat...
Background. Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension ...
Copyright © 2014 Bodil Ivarsson et al. This is an open access article distributed under the Creative...
Introduction: Pulmonary fibrosis includes a spectrum of diseases and is incurable. There is a variat...
Survival rates for patients with idiopathic pulmonary arterial hypertension (IPAH) have improved wit...
Introduction: Spouses play a crucial role, both physically and psychologically, for patients with pu...
Introduction: Pulmonary fibrosis includes a spectrum of diseases and is incurable. There is a variat...
Essentials Diagnostic delay of chronic thromboembolic pulmonary hypertension (CTEPH) is long. We exp...
Pulmonary hypertension (PH) is a complex condition that can occur as a result of a wide range of dis...
ABSTRACT: Poor survival among patients with untreated pulmonary arterial hypertension (PAH) means th...
Pulmonary arterial hypertension (PAH) is a rare, debilitating and rapidly progressive disease. Altho...
Objective: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (...
Purpose: To describe symptoms experienced by pulmonary arterial hyper-tension (PAH) patients and the...